Cargando…
β-RA Targets Mitochondrial Metabolism and Adipogenesis, Leading to Therapeutic Benefits against CoQ Deficiency and Age-Related Overweight
Primary mitochondrial diseases are caused by mutations in mitochondrial or nuclear genes, leading to the abnormal function of specific mitochondrial pathways. Mitochondrial dysfunction is also a secondary event in more common pathophysiological conditions, such as obesity and metabolic syndrome. In...
Autores principales: | Hidalgo-Gutiérrez, Agustín, Barriocanal-Casado, Eliana, Díaz-Casado, María Elena, González-García, Pilar, Zenezini Chiozzi, Riccardo, Acuña-Castroviejo, Darío, López, Luis Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533582/ https://www.ncbi.nlm.nih.gov/pubmed/34680574 http://dx.doi.org/10.3390/biomedicines9101457 |
Ejemplares similares
-
β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9
(R239X) mice
por: Hidalgo‐Gutiérrez, Agustín, et al.
Publicado: (2018) -
The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency
por: González-García, Pilar, et al.
Publicado: (2022) -
Reduction in the levels of CoQ biosynthetic proteins is related to an increase in lifespan without evidence of hepatic mitohormesis
por: Rodríguez-Hidalgo, María, et al.
Publicado: (2018) -
CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome
por: Luna‐Sánchez, Marta, et al.
Publicado: (2016) -
Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease
por: Barriocanal-Casado, Eliana, et al.
Publicado: (2019)